πŸ‡ΊπŸ‡Έ FDA
Patent

US 10815485

RNA interference in skin indications

granted A61PA61P1/16A61P11/00

Quick answer

US patent 10815485 (RNA interference in skin indications) held by Phio Pharmaceuticals Corp. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phio Pharmaceuticals Corp.
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00